New Method Simplifies Testing of HDL Function in Heart Disease Study
A simplified test of HDL's ability to remove cholesterol was associated with high-risk coronary plaques in a study of 61 patients.
A simplified test of HDL's ability to remove cholesterol was associated with high-risk coronary plaques in a study of 61 patients.
Health screening and genetic tests might identify more than one million U.S. adults who carry a gene for familial hypercholesterolemia.
Researchers at two universities have developed a portable device that may diagnose a heart attack in minutes.
Published findings show initial testing for three specific biomarkers may provide superior results over standard screening methods.
Read MoreWith tens of thousands of flu cases, more than 10,000 reported hospitalizations, and scores of deaths—including more than 60 young children—this flu season is the worst in a decade and one of the worst on record.
Read MoreTo find out more about FDA’s recent safety alert and its effects on the clinical laboratory community, CLP recently spoke with Ramani Wonderling, PhD, associate director for scientific relations in diagnostics at Abbott.
Read MoreThe company has received the CE mark for a new high-sensitivity troponin assay that aids in diagnosing myocardial infarction for patients presenting with chest pain or other ischemic symptoms.
Read MoreIn a recent clinical trial conducted in collaboration with the University Hospital of Zurich, the Ava bracelet captured physiological changes known to occur in early pregnancy.
Read MoreA large clinical experience study has evaluated the performance of the Panorama noninvasive prenatal test from Natera Inc.
Read MoreThe campaign is focused on empowering patients with lung cancer and their caregivers to initiate a dialogue with their physicians about comprehensive genomic testing and its potential to expand treatment options for the patient.
Read MoreThe simple blood test identifies individuals who are at risk of experiencing a heart attack, and for whom early intervention can help.
Read MoreAnalysis utilizing single-molecule counting technology developed by Singulex has shown the power to identify patients at risk for worsening heart health.
Read MoreThe collaboration aims to address unmet needs to guide clinical decisions in breast cancer.
Read MoreCurrent and emerging cardiac markers are signaling improved testing for better patient outcomes.
Read MoreAbridged and edited results of a live Q&A session with Donna Mayne, BS, MT(ASCP), (CLS)NCA, microbiology and molecular laboratory manager at Sacred Heart Hospital Pensacola Laboratory, during CLP’s well-attended webcast on “Bacterial Vaginosis: Complications and Diagnostic Options.”
Read MoreNIAID study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Read MoreResearchers seek to better understand the genomic basis of disease, and provide tailored care to patients.
Read MoreReshaping and broadening the future of lab testing, these diagnostic advances are particularly noteworthy for laboratorians as well as for physicians and patients.
Read More